Unknown

Dataset Information

Effect of semaglutide and liraglutide in individuals with obesity or overweight without diabetes: a systematic review.


ABSTRACT:

Background & objective

Although data on the effects of liraglutide and semaglutide in patients with diabetes have been reviewed, their therapeutic outcomes in obese/overweight individuals without diabetes have not been summarized. We conducted a systematic review to evaluate their effects on the latter population.

Methods

We searched the PubMed, EMBASE, Cochrane, CNKI, and Wanfang databases. Studies regarding obese/overweight adults without diabetes treated with liraglutide/semaglutide compared with other active agents or placebos were accessed. The primary outcomes were the proportions of adults with at least 5% and 10% weight reduction. The secondary outcomes included metabolic indicators and adverse events.

Results

Eighteen studies with 10,938 obese/overweight adul

SUBMITTER: Deng Y 

PROVIDER: S-EPMC9260566 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature